A double ‐blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibrillation after coronary artery bypass graft surgery
ConclusionMagnesium administration via the cardioplegic solution during aortic cross‐clamping at doses of 80 and 100 mg/kg can reduce the risk of AF occurrence after CABG compared to the dose of 60 mg/kg. Considering the lower rate of AF incidence and shorter length of ICU stay in patients receiving 100 mg/kg of magnesium, it seems reasonable to administer 100 mg/kg magnesium during aortic cross‐clamp to prevent postoperative AF.
Source: Cardiovascular Therapeutics - Category: Cardiology Authors: Afshin Gholipour Baradari, Amir Emami Zeydi, Rahman Ghafari, Mohsen Aarabi, Mahboubeh Jafari Tags: Original Research Article Source Type: research
More News: Atrial Fibrillation | Calcium | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Coronary Artery Bypass Graft | Heart | Magnesium | Study